US 10,100,101 B2Granted

Compositions and methods related to viral vaccines

AssigneeOhio State Innovation Foundation

InventorDaral John Jackwood

Life of this patent

Estimating the term…

Abstract

Provided herein are methods and compositions relating to Infectious Bursal Disease Virus (IBDV), and vaccines for treatment and prevention thereof.

Claims15

Dependent claims

A polyvalent VP2 trimer of infectious pancreatic necrosis virus (IPNV), wherein the polyvalent VP2 trimer comprises three VP2 monomers, and wherein at least one of the VP2 monomers is from a different strain of IPNV than the other monomers.

Dependencies are inferred from the claim text.

Facts

Application: 15/649,115Filed 13 Jul 2017 · continuation
Priority: 5 Jul 2012
Published: US 2017/0313763 A12 Nov 2017
Granted: 16 Oct 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
A61K 38/162
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from virus
C07K 16/10
Against material from viruses: rNA viruses
C12N 7/00
Viruses

Family

Application61/668,314Us provisional application · filed 5 Jul 2012
PCT/US2013/049453Parent of this continuation · filed 5 Jul 2013
US 2017/0313763 A1Pre-grant publication · published 2 Nov 2017
Application13/982,714Parent of this continuation
US 9,732,144 B2Parent of this continuation
US 2015/0104475 A1Published application
US 10,100,101 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Abstract

Provided herein are methods and compositions relating to Infectious Bursal Disease Virus (IBDV), and vaccines for treatment and prevention thereof.

Facts

Application

15/649,115Filed 13 Jul 2017 · continuation

Priority

5 Jul 2012

Published

US 2017/0313763 A12 Nov 2017

Granted

16 Oct 2018

Term ends

Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
A61K 38/162
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from virus
C07K 16/10
Against material from viruses: rNA viruses
C12N 7/00
Viruses

Family

Application61/668,314Us provisional application · filed 5 Jul 2012

PCT/US2013/049453Parent of this continuation · filed 5 Jul 2013

US 2017/0313763 A1Pre-grant publication · published 2 Nov 2017

Application13/982,714Parent of this continuation

US 9,732,144 B2Parent of this continuation

US 2015/0104475 A1Published application

US 10,100,101 B2This patent

From the US filing history. Foreign family members aren’t listed.